Omicron Boosters Available From Next Month

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });

2022-11-26 HKT 09:22

Share this story

facebook

  • Omicron boosters available from next month

Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.

The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.

"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."

Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.

The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.

The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.

mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.

RECENT NEWS

HKMA Pushes Project Ensemble, Banks To Adopt Tokenised Deposits

The Hong Kong Monetary Authority (HKMA) will advance Project Ensemble and encourage commercial banks in the city to int... Read more

Singapore And Hong Kong Regulators Deepen Cooperation On Bank Oversight

The Monetary Authority of Singapore (MAS) and the Hong Kong Monetary Authority (HKMA) have signed a Memorandum of Under... Read more

XTransfer, SPD Bank Shanghai Partner To Boost Cross-Border Trade For SMEs

XTransfer has entered into a strategic partnership with SPD Bank’s Shanghai Branch, announced at the “XTransfer Tra... Read more

PayPay To Be Accepted At Over 2 Million Merchants In South Korea Via Alipay+

From late September 2025, Japan’s largest cashless payment service, PayPay, will be accepted at more than two million... Read more

Lenovo Hong Kong And Cyberport Partner To Support Startups

Lenovo Hong Kong has announced the signing of a MoU with Cyberport, aimed at supporting Hong Kong’s innovation and te... Read more

PAObank Partners With CPAIHK To Integrate Banking And Insurance Services

PAObank, in which Ping An Insurance holds a stake, is marking its fifth anniversary with a new strategic partnership wi... Read more